Psychedelics
It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety
Hi, what are you looking for?
Mugglehead Magazine
All posts tagged "CYB003"
Psychedelics
CYB003 is a molecule developed by the company with rapid onset and a short duration
Canada
First novel psilocybin compound to commence clinical development marks 'tremendous milestone' for biotechnology company
Cannabis
New license is the final required step before administering doses to study participants
